Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Trubion Announces Acceptance Of Three Presentations On Its TRU-016 Product Candidate At The 2009 ASCO Annual Meeting
Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) announced the acceptance of three data presentations on its proprietary product candidate, TRU-016, that will be given at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting May 29 through June 2 in Orlando, Fla. The presentations will include positive data from a Phase 1 clinical trial of TRU-016 for the treatment of chronic lymphocytic leukemia (CLL), a preclinical study demonstrating the additive or synergistic effects of TRU-016 in combination with other therapeutic drugs for the treatment of non-Hodgkin"s lymphoma (NHL), and a preclinical study evaluating the effect of TRU-016 on direct apoptosis in CLL cells.
generic viagra online
Popular Breast Cancer Drug Used With Certain Antidepressants Puts New Jersey Women At Risk
A new analysis finds that women in New Jersey who take the breast cancer drug tamoxifen in conjunction with certain popular antidepressants may be at a higher risk for a breast cancer recurrence.
News of the day
Type 2 Diabetes: An Epidemic Among America's Youth
With the number of children suffering from type 2 diabetes growing at an alarming rate, physicians gathered Saturday to discuss strategies for prevention and treatment of the disease among children and adolescents at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.
Diagnostics

The Journal "Foot & Ankle Specialist" Accepted In Medline

Foot & Ankle Specialist (FAS), published by SAGE, has been accepted for inclusion in MEDLINE, the premier bibliographic database of the U.S. National Library of Medicine (NLM), containing more than 16 million journal article citations. "FAS is privileged to be among the high-quality journals accepted into MEDLINE," said co-editor Gregory C. Berlet, MD. "Researchers and clinicians concerned with foot and ankle care will now be better able to access and disseminate the techniques and advancements published in the journal." Foot & Ankle Specialist is a peer-reviewed bimonthly journal offering clinical information for foot and ankle caregivers. Written and edited by orthopaedic surgeons and podiatrists, FAS offers the latest techniques and advancements in foot and ankle treatment through research reports and reviews, technical perspectives, case studies, and other evidence-based articles. FAS enables practitioners to address a broad range of disorders and provide their patients with the best current diagnosis and therapy. "SAGE is very pleased to see the important work published in FAS now included in this prestigious database," said Ron Epstein, SAGE Director, STM Journals. "It is a testament to the quality of the work and dedication of the editors Gregory C. Berlet and Babak Baravarian and the entire editorial team." Jim Gilden SAGE Publications


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009